{"id":3788,"date":"2024-06-03T10:41:29","date_gmt":"2024-06-03T08:41:29","guid":{"rendered":"https:\/\/orange-cows.flywheelstaging.com\/?page_id=3788"},"modified":"2025-06-02T11:49:24","modified_gmt":"2025-06-02T09:49:24","slug":"about-royalty-pharma","status":"publish","type":"page","link":"https:\/\/abiconference.com\/staging\/about-royalty-pharma\/","title":{"rendered":"Royalty Pharma"},"content":{"rendered":"<p>Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry\u2019s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly \u2013 directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. For more information, visit <a href=\"https:\/\/www.royaltypharma.com\/\" target=\"_blank\" rel=\"noopener\">www.royaltypharma.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":5926,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"about.php","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-3788","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/abiconference.com\/staging\/wp-json\/wp\/v2\/pages\/3788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/abiconference.com\/staging\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/abiconference.com\/staging\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/abiconference.com\/staging\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/abiconference.com\/staging\/wp-json\/wp\/v2\/comments?post=3788"}],"version-history":[{"count":6,"href":"https:\/\/abiconference.com\/staging\/wp-json\/wp\/v2\/pages\/3788\/revisions"}],"predecessor-version":[{"id":5430,"href":"https:\/\/abiconference.com\/staging\/wp-json\/wp\/v2\/pages\/3788\/revisions\/5430"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/abiconference.com\/staging\/wp-json\/wp\/v2\/media\/5926"}],"wp:attachment":[{"href":"https:\/\/abiconference.com\/staging\/wp-json\/wp\/v2\/media?parent=3788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}